REGENSBURG, Germany--(BUSINESS WIRE)--Transcatheter Technologies GmbH, a emerging medical device company that is developing a next-generation transcatheter aortic heart valve prosthesis, announced today the successful first-in-human implantation of its transapical TRINITY aortic valve designed to be the world’s best repositionable heart valve.
Help employers find you! Check out all the jobs and post your resume.
